跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
24HR NASAL ALLERGY RELIEF - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
24HR NASAL ALLERGY RELIEF
Authorized
STANDARD
24HR NASAL ALLERGY RELIEF
Apotex Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
1e15d9d49f11fc26
Company
Apotex Inc
Type
Standard
Approval Details
Approval Id
1e15d9d49f11fc26
Drug Approval Canada Name
24HR NASAL ALLERGY RELIEF
Product Name
24HR NASAL ALLERGY RELIEF
Status
Marketed
Status Date
2017-07-19
Original Market Date
2017-07-19
Din
02460513
Drug Class
Human
Dosage Form
Spray, Metered Dose
Route Of Administration
Nasal
Schedule
OTC
Ahfs
52:08.08
Atc Original
R01AD08 FLUTICASONE
Atc Name
r 01 ad 08
Aig Number
0124685001
Company Name
Apotex Inc
Company Address
150 Signet Drive, Toronto, Ontario, Canada, M9L 1T9
Company Detail Path
/organization/apotex-inc
Company Information
Pharmaceutical Company Name
Apotex Inc
Country Name
Canada
Province Name
Ontario
City Name
toronto,ontario,country_ca
Address
150 Signet Dr
Active Ingredients
FLUTICASONE PROPIONATE
50 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
1e15d9d49f11fc26
Type
Standard
Back to Health Canada Approvals